exoASO-NRAS

N/A

Report date: 2022/03/16 17:41:22
NME

Base Information

Drug NameexoASO-NRAS
Drug Alias NameexoASO-NRAS
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGTPase NRas inhibitorsRNA interference
TargetsGTPase NRas
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCodiak Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCodiak Biosciences
Active IndicationsN/A
Inactive IndicationsSolid tumoursHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A